Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Diazepam (generic) from Natco Pharma USA LLC under an ANDA. The action confirms approval of the …
-
FDA approval · 2021-02-06FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Paxil (paroxetine hydrochloride) submitted by Apotex Corp.
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA supplemental approval for a generic chlordiazepoxide and amitriptyline hydrochloride product from Mylan Pharmaceuticals.
-
FDA approval · 2021-02-05FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Alprazolam submitted by Mylan Pharmaceuticals, contributing to the existing approval for thi…
-
FDA approval · 2021-02-05FDA Approved: XANAX XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for XANAX XR (alprazolam) from Viatris Specialty LLC. The action involves changes to the product…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc. to market a generic diazepam product.
-
FDA approval · 2021-02-05FDA Approved: ALPRAZOLAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for alprazolam by Actavis Pharma, Inc., enabling a generic alprazolam product.
-
FDA approval · 2020-12-30FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for duloxetine (ANDA204343), enabling the continued marketing of the gener…
-
FDA approval · 2020-11-03FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for venlafaxine hydrochloride (generic) under ANDA076565, enabling it…
-
FDA approval · 2020-10-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (XLCare Pharmaceuticals, Inc.)
FDA approved the generic venlafaxine hydrochloride (venlafaxine) under Original Application for the treatment of major depressive disorder, …
-
FDA approval · 2020-10-01FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2020-07-28FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Contract Pharmacal Corp.)
FDA approved an original application for doxepin hydrochloride, a generic product from Contract Pharmacal Corp., with labeling for major dep…
-
FDA approval · 2020-07-21FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Paroxetine hydrochloride from Apotex Corp., enabling continued marketing of a generic product.
-
FDA approval · 2020-05-29FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for buspirone hydrochloride from Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2020-05-29FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for buspirone hydrochloride, approving a generic version from Rising Pharma Holdings, Inc.
-
FDA approval · 2020-05-28FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for buspirone hydrochloride from Oxford Pharmaceuticals, LLC under the Abbreviated New Drug Applicat…
-
FDA approval · 2020-05-28FDA Approved: BUSPIRONE HCL — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for Buspirone hydrochloride (Buspirone HCl) filed by Advagen Pharma Ltd under ANDA075521, adding…
-
FDA approval · 2020-04-20FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly, granting updated labeling under the NDA.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for venlafaxine by BluePoint Laboratories, expanding its generic availability.
-
FDA approval · 2020-04-14FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride (generic Venlafaxine) by Aurobindo Pharma Limited.
-
FDA approval · 2020-04-10FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals.
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…
-
FDA approval · 2020-03-23FDA Approved: PREGABALIN — Original Application (Creekwood Pharmaceuticals LLC)
FDA approves Creekwood Pharmaceuticals LLC's Original Application (ANDA) for pregabalin, enabling a generic version of the drug. This action…
-
FDA approval · 2020-03-17FDA Approved: OXAZEPAM — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for Oxazepam from TruPharma, LLC.
-
FDA approval · 2020-03-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)
FDA approved the original application for venlafaxine hydrochloride by Advagen Pharma Ltd., authorizing a generic version of this antidepres…